These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma. Lei B; Qi W; Zhao Y; Li Y; Liu S; Xu X; Zhi C; Wan L; Shen H Hum Pathol; 2015 Feb; 46(2):217-24. PubMed ID: 25466965 [TBL] [Abstract][Full Text] [Related]
3. miR-216b promotes cell growth and enhances chemosensitivity of colorectal cancer by suppressing PDZ-binding kinase. Zou J; Kuang W; Hu J; Rao H Biochem Biophys Res Commun; 2017 Jun; 488(2):247-252. PubMed ID: 28373071 [TBL] [Abstract][Full Text] [Related]
4. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21. Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma. Ohashi T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Imamura T; Kiuchi J; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E Br J Cancer; 2017 Jan; 116(2):218-226. PubMed ID: 27898655 [TBL] [Abstract][Full Text] [Related]
6. Gossypetin Inhibits Solar-UV Induced Cutaneous Basal Cell Carcinoma Through Direct Inhibiting PBK/TOPK Protein Kinase. Wang L; Zhang Z; Ge R; Zhang J; Liu W; Mou K; Lv S; Mu X Anticancer Agents Med Chem; 2019; 19(8):1029-1036. PubMed ID: 30827262 [TBL] [Abstract][Full Text] [Related]
7. Baicalin suppresses lung cancer growth by targeting PDZ-binding kinase/T-LAK cell-originated protein kinase. Diao X; Yang D; Chen Y; Liu W Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898980 [TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of PDZ-binding kinase/T-LAK cell-originated protein kinase modulates the invasive ability of human pancreatic cancer cells via the stabilization of oncoprotein c-MYC. Hinzman CP; Aljehane L; Brown-Clay JD; Kallakury B; Sonahara F; Goel A; Trevino J; Banerjee PP Carcinogenesis; 2018 Dec; 39(12):1548-1559. PubMed ID: 30165468 [TBL] [Abstract][Full Text] [Related]
9. PBK/TOPK mediates promyelocyte proliferation via Nrf2-regulated cell cycle progression and apoptosis. Liu Y; Liu H; Cao H; Song B; Zhang W; Zhang W Oncol Rep; 2015 Dec; 34(6):3288-96. PubMed ID: 26503118 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase (PBK/TOPK) in Patients with Cancer. Zhang Y; Yang X; Wang R; Zhang X J Cancer; 2019; 10(1):131-137. PubMed ID: 30662533 [No Abstract] [Full Text] [Related]
11. Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma. Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML Immunobiology; 2014 Jun; 219(6):469-74. PubMed ID: 24629784 [TBL] [Abstract][Full Text] [Related]
12. PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression. Lei B; Liu S; Qi W; Zhao Y; Li Y; Lin N; Xu X; Zhi C; Mei J; Yan Z; Wan L; Shen H Histopathology; 2013 Nov; 63(5):696-703. PubMed ID: 24025073 [TBL] [Abstract][Full Text] [Related]
13. PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer. Park JH; Lin ML; Nishidate T; Nakamura Y; Katagiri T Cancer Res; 2006 Sep; 66(18):9186-95. PubMed ID: 16982762 [TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays. Su TC; Chen CY; Tsai WC; Hsu HT; Yen HH; Sung WW; Chen CJ PLoS One; 2018; 13(10):e0204866. PubMed ID: 30286126 [TBL] [Abstract][Full Text] [Related]
15. Mitotic kinase PBK/TOPK as a therapeutic target for adult T‑cell leukemia/lymphoma. Ishikawa C; Senba M; Mori N Int J Oncol; 2018 Aug; 53(2):801-814. PubMed ID: 29901068 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of PBK/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma. Ohashi T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Imamura T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E Anticancer Res; 2016 Dec; 36(12):6457-6466. PubMed ID: 27919968 [TBL] [Abstract][Full Text] [Related]
18. Protein expression of PDZ-binding kinase is up-regulated in hematologic malignancies and strongly down-regulated during terminal differentiation of HL-60 leukemic cells. Nandi A; Tidwell M; Karp J; Rapoport AP Blood Cells Mol Dis; 2004; 32(1):240-5. PubMed ID: 14757441 [TBL] [Abstract][Full Text] [Related]